arrow
R

Robert C. Doebele

h lee moffitt cancer center & research institute
H指数:74
被引数:3.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer (vol 24, pg 638, 2018)
2024-08-200
OA
Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas
2023-11-011
OA
Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas
2023-10-012
PRE
Cell-free DNA detection of GATA3 mutations in metastatic hormone receptor positive breast cancer: a retrospective, observational multi-institutional analysis
2023-03-010
PRE
James DeCaprio1,2,3 1 . 2 . 3 . 4 . 5
2022-07-087
OA
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers (vol 5, 373, 2022)
2022-07-040
OAAI
Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion-Positive NSCLC

Entrectinib治疗ROS1融合阳性NSCLC的长期疗效和安全性

2022-06-0172
OA
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
2022-04-1911
OAAI